The 5-hydroxytryptamine (5-HT) system, which includes the 5-HT transporters, 5-HT receptors and monoamine oxidase A (MAO-A), has been used as a drug target in the pharmacotherapeutics for depression. The gene discussed is MAOA; the disease is depressive symptom measurement.